Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-13
5:53 pm
Purchase
13GViracta Therapeutics, Inc.
VIRX
BIOTECHNOLOGY VALUE FUND L P3,833,785
9.98%
102,041increase
(+2.73%)
View
2023-01-10
5:21 pm
Unchanged
13DViracta Therapeutics, Inc.
VIRX
Schindel Yair Chaim7,392,237
19.35%
0
(Unchanged)
View
2022-07-08
4:56 pm
Sale
13GViracta Therapeutics, Inc.
VIRX
BlackRock Inc.
BLK
542,431
1.4%
-1,826,487decrease
(-77.10%)
View
2022-02-15
1:48 pm
Sale
13GViracta Therapeutics, Inc.
VIRX
LYTTON LAURENCE W255,876
0.7%
-1,342,643decrease
(-83.99%)
View
2022-02-14
1:33 pm
Purchase
13GViracta Therapeutics, Inc.
VIRX
BIOTECHNOLOGY VALUE FUND L P3,731,744
9.9%
1,917,436increase
(+105.68%)
View
2022-02-14
12:14 pm
Sale
13GViracta Therapeutics, Inc.
VIRX
Aisling Capital IV LP288,571
0.77%
-9,811,429decrease
(-97.14%)
View
2022-02-09
5:24 pm
Purchase
13GViracta Therapeutics, Inc.
VIRX
FORWARD VENTURES V LP2,664,790
7.14%
42,516increase
(+1.62%)
View
2022-02-04
4:12 pm
Purchase
13GViracta Therapeutics, Inc.
VIRX
BlackRock Inc.
BLK
2,368,918
6.3%
248,387increase
(+11.71%)
View
2021-03-10
9:40 pm
Sale
13DViracta Therapeutics, Inc.
VIRX
New Enterprise Associates 12 Limited Partnership0
0%
-7,789,644decrease
(Position Closed)
View
2021-03-08
5:05 pm
Purchase
13GViracta Therapeutics, Inc.
VIRX
FORWARD VENTURES V LP2,622,274
7.09%
2,622,274increase
(New Position)
View
2021-03-05
1:30 pm
Unchanged
13GViracta Therapeutics, Inc.
VIRX
LVP LIFE SCIENCE VENTURES III L.P.3,124,094
8.44%
0
(Unchanged)
View
2021-03-02
06:14 am
Unchanged
13DViracta Therapeutics, Inc.
VIRX
Schindel Yair Chaim7,392,237
19.98%
0
(Unchanged)
View
2021-02-16
3:50 pm
Sale
13GSUNESIS PHARMACEUTICALS INC
SNSS
CAXTON CORP0
0%
-8,134,926decrease
(Position Closed)
View
2021-02-16
11:06 am
Sale
13GSUNESIS PHARMACEUTICALS INC
SNSS
Ayrton Capital LLC0
0%
-10,869,565decrease
(Position Closed)
View
2021-02-16
09:50 am
Sale
13GSUNESIS PHARMACEUTICALS INC
SNSS
CVI Investments Inc.0
0%
-8,695,652decrease
(Position Closed)
View
2021-02-16
06:24 am
Sale
13GSUNESIS PHARMACEUTICALS INC
SNSS
Nantahala Capital Management LLC0
0%
-8,765,600decrease
(Position Closed)
View
2021-02-12
6:47 pm
Sale
13GSUNESIS PHARMACEUTICALS INC
SNSS
BIOTECHNOLOGY VALUE FUND L P1,814,308
9.98%
-9,839,617decrease
(-84.43%)
View
2021-01-07
08:39 am
Sale
13GSUNESIS PHARMACEUTICALS INC
SNSS
SABBY MANAGEMENT LLC0
0%
-10,869,565decrease
(Position Closed)
View
2021-01-04
12:35 pm
Purchase
13GSUNESIS PHARMACEUTICALS INC
SNSS
LYTTON LAURENCE W1,598,519
8.8%
1,598,519increase
(New Position)
View
2020-08-07
2:51 pm
Purchase
13GSUNESIS PHARMACEUTICALS INC
SNSS
Ayrton Capital LLC10,869,565
6.65%
10,869,565increase
(New Position)
View
Goto 0, 1, 2, Next